Kevin W. McConeghy Pharm.D, Michael Cinque Pharm.D, Elizabeth M. White APRN, PhD, Richard A. Feifer MD, MPH, Carolyn Blackman MD, Vincent Mor PhD, Stefan Gravenstein MD, MPH, Andrew R. Zullo Pharm.D, PhD
Abstract
Background
At the height of the COVID-19 pandemic, a large nursing home chain implemented a policy to temporarily hold potentially unnecessary medications. We describe rates of held and discontinued medications after a temporary hold policy of potentially unnecessary or nonessential medications.
Methods
This retrospective cohort study uses electronic health record (EHR) data on 3247 residents of 64 nursing homes operated by a multistate long-term care provider. Medications were documented in the electronic medication administration record. Overall medication held and discontinued incidences are reported. Hierarchical Bayesian modeling is used to determine individual probabilities for medication discontinuation within each facility.
Results
In total, 3247 residents had 5297 nonessential medications held. Multivitamins were most likely to be held, followed by histamine-2 receptor antagonists, antihistamines, and statins. At the end of the hold policy, 2897 of 5297 (54%) were permanently discontinued, including probiotics (73%), histamine-2 receptor antagonists (66%), antihistamines (64%), and statins (45%). Demographics, cognitive and functional impairment were similar between residents with medications who were discontinued versus continued. For most medications, more than 50% of the variance in whether medications were discontinued was explained by facility rather than resident-level factors.
Conclusion
A temporary medication hold policy implemented during the CoVID-19 pandemic led to the deprescribing of a plurality of ‘nonessential’ medications. This type of organization-wide initiative may be an effective mechanism for altering future prescribing behaviors to reduce the use of unnecessary medications.